The 5’-Untranslated Region of the C9orf72 mRNA Exhibits a Phylogenetic Alignment to the Cis-Aconitase Iron-Responsive Element; Novel Therapies for Amytrophic Lateral Sclerosis

ISSN Print: 2158-2912
ISSN Online: 2158-2947
www.scirp.org/journal/nm
E-mail: nm@scirp.org

"The 5’-Untranslated Region of the C9orf72 mRNA Exhibits a Phylogenetic Alignment to the Cis-Aconitase Iron-Responsive Element; Novel Therapies for Amytrophic Lateral Sclerosis"
written by Monica A. Lu, Susruthi Rajanala, Sohan V. Mikkilineni, Catherine M. Cahill, Robert Brown, James D. Berry, Jack T. Rogers,
published by Neuroscience and Medicine, Vol.7 No.1, 2016

has been cited by the following article(s):

[1]	Conservation in the Iron Responsive Element Family
	Genes, 2021

[2]	Therapeutic Roles Of Antioxidant And Nutraceuticals In The Prevention And Management Of Alzheimer'S Disease: A Systematic Review
	Biomedical …, 2021

[3]	H63D HFE AS A GENETIC MODIFIER OF PARKINSON'S DISEASE: CLINICAL IMPACTS AND MOLECULAR MECHANISMS
	2020

[4]	The roles of iron and HFE genotype in neurological diseases
	2020

[5]	Iron-responsive-like elements and neurodegenerative ferroptosis
	2020

[6]	Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials
	2020

[7]	Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis
	2020

[8]	Targeting the Iron-Response Elements of the mRNAs for the Alzheimer's Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity
	2019

[9]	Targeting the Iron-Response Elements of the mRNAs for the Alzheimer's Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese …
	2019

[10]	Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis?
	2017

[11]	Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease
	Pharmacological Research, 2017

[1]	Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer’s Disease Journal of Alzheimer's Disease, 2023 DOI:10.3233/JAD-230953

[2]	Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis Journal of Neural Transmission, 2020 DOI:10.1007/s00702-019-02138-1

[3]	Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials Expert Opinion on Emerging Drugs, 2020 DOI:10.1080/14728214.2020.1769067

[4]	Iron-responsive-like elements and neurodegenerative ferroptosis Learning & Memory, 2020 DOI:10.1101/lm.052282.120

[5]	The roles of iron and HFE genotype in neurological diseases Molecular Aspects of Medicine, 2020 DOI:10.1016/j.mam.2020.100867

[6]	Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity International Journal of Molecular Sciences, 2019 DOI:10.3390/ijms20040994

[7]	Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis? Antioxidants & Redox Signaling, 2018 DOI:10.1089/ars.2017.7493

[8]	Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer’s disease Pharmacological Research, 2017 DOI:10.1016/j.phrs.2017.11.028